Skip to main content
. 2020 Aug 27;2(3):zcaa019. doi: 10.1093/narcan/zcaa019

Figure 4.

Figure 4.

Lymphoma spectrum in Ung−/− and Ung−/− Aicda−/− mice. (A) Proportion of lymphoma types found in each mouse line from the prospective cohort. (B) Examples of BCL and TCL in Ung−/− mice. Representative microscopy images of tissue sections stained by IHC with anti-B220 or anti-CD3 (bars = 50 μm) and flow cytometry plots. (C) Examples of BCL in Ung−/− Aicda−/− mice. Representative microscopy images of tissue sections stained with hematoxylin and eosin or by IHC with anti-B220 (bars = 50 μm), and flow cytometry plots. (D) Summary of the expression of the indicated markers monitored in BCL by IHC (Bcl6, PNA; see Supplementary Figure S5) or flow cytometry (CD21, CD23; see Supplementary Figure S4). Features typically found in activated (PNA+ Bcl6low CD21 CD23+), GC (Bcl6+ PNA+ CD21low CD23low/−) or post-GC (PNA Bcl6 CD21 CD23) B cells are shaded.